Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Orano Moed Invests US$262.7 million (€250 mn) for New Production Facility in USA
Orano Moed is set to invest US$2627 million 250 million in a new Advanced Thorium Extraction Facility ATEF in the USA
GSK Invests US$800 million to Open New State-of-the-art Drug Manufacturing Facility in USA
GSK plans to invests US$800 million to open new stateoftheart facilities for the production of medicines and vaccinesin USA
Eli Lilly Invests US$3 billion to Expand Manufacturing Facility in Wisconsin, USA
Eli Lilly plans to invest US$3 billion for the expansion of its manufacturing facility in Wisconsin, USA
Ardena Invests US$20 million for State-of-the-Art Nanomedicine Facility in Netherlands
Ardena plans to invest US$20 million to open new expanded nanomedicine facility in Oss, Netherlands
Novo Nordisk Invests US$1.8 billion for New Drug Plant in Missouri, USA
Novo Nordisk plans to invest US$18 billion in the construction of a new pharmaceutical manufacturing facility in Missouri, USA
Lonza to Expand with Two Additional Manufacturing Suites in Switzerland
Lonza plans for the expansion of additional bioconjugation capabilities in Switzerland
AmbioPharm Invests US$28mn for the Expansion of Pharmaceutical Manufacturing Site in Shanghai, China
AmbioPharm invests US$28 million for the expansion of pharmaceutical manufacturing site in Shanghai, China
Rentschler Biopharma Plans for the Construction of a New State-of-the-Art Buffer Media Station in Germany
Rentschler Biopharma is set to build a new stateoftheart buffer media station in Laupheim, Germany
Merck Invests US$74.9 million (€70 million) to Expand Manufacturing Capacity in Missouri, USA
Merck is investing $749 million 70 million to enhance its ADC manufacturing capabilities and capacity at its bioconjugation center of excellence in St Louis, Missouri, USA
SK pharmteco Invests US$260 million to Expand Peptide Production in South Korea
SK pharmteco invests US$260 million to expand its small molecule and peptide production capabilities in South Korea A new fivestory, 136,000 squarefoot multipurpose building is being developed to enhance capacity and capabilities
